These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 11867564)

  • 21. Infection-induced up-regulation of the costimulatory molecule 4-1BB in osteoblastic cells and its inhibitory effect on M-CSF/RANKL-induced in vitro osteoclastogenesis.
    Saito K; Ohara N; Hotokezaka H; Fukumoto S; Yuasa K; Naito M; Fujiwara T; Nakayama K
    J Biol Chem; 2004 Apr; 279(14):13555-63. PubMed ID: 14729681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amplification of tumor immunity by gene transfer of the co-stimulatory 4-1BB ligand: synergy with the CD28 co-stimulatory pathway.
    Melero I; Bach N; Hellström KE; Aruffo A; Mittler RS; Chen L
    Eur J Immunol; 1998 Mar; 28(3):1116-21. PubMed ID: 9541607
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Constitutive expression of functional 4-1BB (CD137) ligand on carcinoma cells.
    Salih HR; Kosowski SG; Haluska VF; Starling GC; Loo DT; Lee F; Aruffo AA; Trail PA; Kiener PA
    J Immunol; 2000 Sep; 165(5):2903-10. PubMed ID: 10946324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 4-1BB-specific monoclonal antibody promotes the generation of tumor-specific immune responses by direct activation of CD8 T cells in a CD40-dependent manner.
    Miller RE; Jones J; Le T; Whitmore J; Boiani N; Gliniak B; Lynch DH
    J Immunol; 2002 Aug; 169(4):1792-800. PubMed ID: 12165501
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of tumour necrosis factor (TNF) ligand superfamily co-stimulatory molecules CD30L, CD27L, OX40L, and 4-1BBL in murine hearts with acute myocarditis caused by Coxsackievirus B3.
    Seko Y; Takahashi N; Oshima H; Shimozato O; Akiba H; Takeda K; Kobata T; Yagita H; Okumura K; Azuma M; Nagai R
    J Pathol; 2001 Dec; 195(5):593-603. PubMed ID: 11745696
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD28-independent costimulation of T cells by OX40 ligand and CD70 on activated B cells.
    Akiba H; Oshima H; Takeda K; Atsuta M; Nakano H; Nakajima A; Nohara C; Yagita H; Okumura K
    J Immunol; 1999 Jun; 162(12):7058-66. PubMed ID: 10358148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 4-1BB (CD137) differentially regulates murine in vivo protein- and polysaccharide-specific immunoglobulin isotype responses to Streptococcus pneumoniae.
    Wu ZQ; Khan AQ; Shen Y; Wolcott KM; Dawicki W; Watts TH; Mittler RS; Snapper CM
    Infect Immun; 2003 Jan; 71(1):196-204. PubMed ID: 12496166
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 4-1BB ligand stimulation enhances myeloid dendritic cell maturation from human umbilical cord blood CD34+ progenitor cells.
    Kim YJ; Li G; Broxmeyer HE
    J Hematother Stem Cell Res; 2002 Dec; 11(6):895-903. PubMed ID: 12590704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Provision of 4-1BB ligand enhances effector and memory CTL responses generated by immunization with dendritic cells expressing a human tumor-associated antigen.
    Wiethe C; Dittmar K; Doan T; Lindenmaier W; Tindle R
    J Immunol; 2003 Mar; 170(6):2912-22. PubMed ID: 12626542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of TNF receptor-associated factor 2 and p38 mitogen-activated protein kinase activation during 4-1BB-dependent immune response.
    Cannons JL; Choi Y; Watts TH
    J Immunol; 2000 Dec; 165(11):6193-204. PubMed ID: 11086053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Soluble CD137 (4-1BB) ligand is released following leukocyte activation and is found in sera of patients with hematological malignancies.
    Salih HR; Schmetzer HM; Burke C; Starling GC; Dunn R; Pelka-Fleischer R; Nuessler V; Kiener PA
    J Immunol; 2001 Oct; 167(7):4059-66. PubMed ID: 11564827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 4-1BB ligand activates bystander dendritic cells to enhance immunization in trans.
    Macdonald DC; Hotblack A; Akbar S; Britton G; Collins MK; Rosenberg WC
    J Immunol; 2014 Nov; 193(10):5056-64. PubMed ID: 25305314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cross-linking of 4-1BB activates TCR-signaling pathways in CD8+ T lymphocytes.
    Nam KO; Kang H; Shin SM; Cho KH; Kwon B; Kwon BS; Kim SJ; Lee HW
    J Immunol; 2005 Feb; 174(4):1898-905. PubMed ID: 15699116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T cell activation with systemic agonistic antibody versus local 4-1BB ligand gene delivery combined with interleukin-12 eradicate liver metastases of breast cancer.
    Martinet O; Divino CM; Zang Y; Gan Y; Mandeli J; Thung S; Pan PY; Chen SH
    Gene Ther; 2002 Jun; 9(12):786-92. PubMed ID: 12040460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased soluble 4-1BB ligand (4-1BBL) levels in peripheral blood of patients with multiple sclerosis.
    Liu GZ; Gomes AC; Putheti P; Karrenbauer V; Kostulas K; Press R; Hillert J; Hjelmström P; Gao XG
    Scand J Immunol; 2006 Oct; 64(4):412-9. PubMed ID: 16970683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 4-1BB promotes long-term survival in skin allografts treated with anti-CD45RB and anti-CD40L monoclonal antibodies.
    Lee J; Lee EN; Kim EY; Lee HJ; Park HJ; Sun CL; Lee SK; Joh JW; Lee KW; Kwon GY; Kim SJ
    Transplant Proc; 2005; 37(1):123-5. PubMed ID: 15808569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of programmed death 1 ligands by murine T cells and APC.
    Yamazaki T; Akiba H; Iwai H; Matsuda H; Aoki M; Tanno Y; Shin T; Tsuchiya H; Pardoll DM; Okumura K; Azuma M; Yagita H
    J Immunol; 2002 Nov; 169(10):5538-45. PubMed ID: 12421930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The systemic administration of Ig-4-1BB ligand in combination with IL-12 gene transfer eradicates hepatic colon carcinoma.
    Xu DP; Sauter BV; Huang TG; Meseck M; Woo SL; Chen SH
    Gene Ther; 2005 Oct; 12(20):1526-33. PubMed ID: 15973445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 4-1BB costimulation is required for protective anti-viral immunity after peptide vaccination.
    Tan JT; Whitmire JK; Murali-Krishna K; Ahmed R; Altman JD; Mittler RS; Sette A; Pearson TC; Larsen CP
    J Immunol; 2000 Mar; 164(5):2320-5. PubMed ID: 10679066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Production of recombinant human trimeric CD137L (4-1BBL). Cross-linking is essential to its T cell co-stimulation activity.
    Rabu C; Quéméner A; Jacques Y; Echasserieau K; Vusio P; Lang F
    J Biol Chem; 2005 Dec; 280(50):41472-81. PubMed ID: 16204238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.